J Microbiol Immunol Infect . Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered pat

[tetano]

J Microbiol Immunol Infect


. 2020 Aug 6;S1684-1182(20)30174-2.
doi: 10.1016/j.jmii.2020.07.017. Online ahead of print.
Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2


Fang Liu[SUP] 1 [/SUP], Zhao-Bin Cai[SUP] 2 [/SUP], Jin-Song Huang[SUP] 2 [/SUP], Hai-Ying Niu[SUP] 1 [/SUP], Wen-Yan Yu[SUP] 1 [/SUP], Yan Zhang[SUP] 1 [/SUP], Ting-Bo Yan[SUP] 3 [/SUP], Chen Chen[SUP] 4 [/SUP], Yuan Liu[SUP] 1 [/SUP], Ai-Fang Xu[SUP] 5 [/SUP]



Affiliations

• PMID: 32807688
• DOI: 10.1016/j.jmii.2020.07.017

Abstract

A case who revealed the longest duration of viral shedding (67 days) in current reports, presented complicated characteristic on the relapse of COVID-19 due to the inconsistent performance of chest radiography and SARS-CoV-2-RNA detection after discharge. Lopinavir-interferon α2b boosted ribavirin following with lopinavir boosted budesonide might be a potent treatment for viral clearance.

Keywords: Coronavirus disease 2019; Prognosis; Recovered patients; SARS-CoV-2 re-positive; Viral shedding.